“…As a result of evidence that second respiratory infections with Coccidioides immitis rarely, if ever, occur in nature (Smith, 1957), and that dissemination beyond the regional lymph nodes is extremely rare in naturally or laboratory-acquired primary cutaneous coccidioidomycosis (Wilson, Smith, and Plunkett, 1953;Guy and Jacobs, 1926;Trimble and Doucette, 1956; Wright, Newcomer, and Nelson, 1959;Johnson et al, 1964; Meis, 1961;Winn, 1961Winn, , 1964; Harrell and Honeycutt, 1963; Goodman and Schabarum, 1963), studies on a viable vaccine against coccidioidomycosis were initiated. Previous studies of such a vaccine by Pappagianis et al (1959) and Converse et al (1962a) in mice, and by Pappagianis et al (1960) in cynamolgus monkeys, had indicated the feasibility of this method of protection against the disease.…”